Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- Check4 days agoChange DetectedThe revision label in the site footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the full content, showing a minimal error layout with the site header and footer. This indicates blocked access to the page and a shift away from the previous study-related content and links.SummaryDifference20%

- Check25 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0. This reflects an updated document or protocol version associated with the study page.SummaryDifference0.0%

- Check39 days agoChange DetectedThe revision label on the page has been updated from v3.6.5 to v3.6.6, signaling a small update to the document/version of the page.SummaryDifference0.0%

- Check46 days agoChange DetectedAn NIH grant/contract entry was added to the study identifiers, indicating NIH funding associated with the trial.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 in the study documentation. This indicates a minor, internal update to the study materials.SummaryDifference0.0%

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.